IONIS PHARMACEUTICALS INC

By person

21 insiders · 146 transactions

11.9×

Brett P. Monia holds 11.9 times base salary in stock. $12.53M of shares against $1.05M in salary for 2025.

Salary from the company's own proxy. The shares are what Brett P. Monia last reported holding, valued at $51.60, the price Common Stock was last bought or sold at on the open market here, on 31 Jul 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Monia Brett P

Chief Executive Officer

—

$30.35M (14) scheduled

−$30.35M

242,760

0.1461%

$12.53M

+39.5%

HOUGEN ELIZABETH L

EVP, Finance & CFO

—

$21.12M (6) scheduled

−$21.12M

82,660

0.0497%

$4.27M

−11.0%

BENNETT C FRANK

EVP, Chief Scientific Officer

—

$16.71M (10) scheduled

−$16.71M

60,128

0.0362%

$3.10M

−28.9%

Geary Richard S

EVP, Chief Development Officer

—

$13.23M (10) scheduled

−$13.23M

59,657

0.0359%

$3.08M

−29.7%

O'NEIL PATRICK R.

EVP CLO & General Counsel

—

$9.17M (10) scheduled

−$9.17M

59,205

0.0356%

$3.05M

+21.1%

Devers Shannon L.

EVP, Chief Human Resources Ofc

—

$8.66M (14) scheduled

−$8.66M

16,348

0.0098%

$843.56K

+106.7%

Swayze Eric

EVP Research

—

$7.51M (12) scheduled

−$7.51M

22,077

0.0133%

$1.14M

−36.9%

LOSCALZO JOSEPH

Director

—

$7.09M (5) scheduled

−$7.09M

36,330

0.0219%

$1.87M

−20.6%

KLEIN JOSEPH III

Director

—

$6.00M (12) scheduled

−$6.00M

11,014

0.0066%

$568.32K

−32.6%

WENDER JOSEPH H

Director

—

$5.44M (7) scheduled

−$5.44M

52,035

0.0313%

$2.69M

−67.6%

Diaz Allene M.

Director

—

$5.22M (4) scheduled

−$5.22M

3,811

0.0023%

$196.65K

−75.8%

Kordasiewicz Holly B.

EVP, Chief Development Officer

—

$4.81M (4) scheduled

−$4.81M

22,096

0.0133%

$1.14M

+42.7%

Schneider Eugene

EVP, Chf Clinical Develop Ofcr

—

$3.74M (4) scheduled

−$3.74M

77,114

0.0464%

$3.98M

+26.7%

Baroldi Joseph

EVP, Chief Business Officer

—

$3.70M (13) scheduled

−$3.70M

49,578

0.0298%

$2.56M

+129.6%

Birchler Brian

EVP, Corp and Development Ops

—

$3.56M (6) scheduled

−$3.56M

102,883

0.0619%

$5.31M

+26.2%

Jenne Kyle

EVP, Chf GL Pdt Str Ofcr

—

$3.33M (4) scheduled

−$3.33M

23,713

0.0143%

$1.22M

+1,092%

HERMAN JOAN E

Director

—

$3.17M (2) scheduled

−$3.17M

51,306

0.0309%

$2.65M

+22.1%

BERTHELSEN SPENCER R

Director

—

$1.19M (2) scheduled

−$1.19M

161,233

0.0970%

$8.32M

+6.1%

PARSHALL B LYNNE

Director

—

$1.15M (4) scheduled

−$1.15M

51,344

0.0309%

$2.65M

−41.2%

Hayden Michael R

Director

$1.06M (2)

—

+$1.06M

78,298

0.0471%

$4.04M

+128.8%

YANG MICHAEL J.

Director

—

7,940

0.0048%

$409.70K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Baroldi Joseph

16 Apr 2026

EVP, Chief Business Officer

Sell

5,619

$74.56

$418.95K

Birchler Brian

16 Apr 2026

EVP, Corp and Development Ops

Sell

973

$75.04

$73.02K

Jenne Kyle

16 Apr 2026

EVP, Chf GL Pdt Str Ofcr

Sell

4,902

$75.17

$368.49K

Baroldi Joseph

30 Jan 2026

EVP, Chief Business Officer

Sell

5,296

$82.96

$439.36K

BENNETT C FRANK

30 Jan 2026

EVP, Chief Scientific Officer

Sell

5,885

$82.95

$488.14K

Birchler Brian

30 Jan 2026

EVP, Corp and Development Ops

Sell

6,179

$83.03

$513.05K

HOUGEN ELIZABETH L

30 Jan 2026

EVP, Finance & CFO

Sell

6,988

$83.24

$581.70K

Monia Brett P

30 Jan 2026

Chief Executive Officer

Sell

62,970

$82.72

$5.21M

O'NEIL PATRICK R.

30 Jan 2026

EVP CLO & General Counsel

Sell

6,179

$83.53

$516.15K

Schneider Eugene

30 Jan 2026

EVP, Chf Clinical Develop Ofcr

Sell

6,179

$83.45

$515.63K

Swayze Eric

30 Jan 2026

EVP Research

Sell

6,179

$82.93

$512.45K

Baroldi Joseph

16 Jan 2026

EVP, Chief Business Officer

Sell indirect

1,149

$75.78

$87.07K

Baroldi Joseph

16 Jan 2026

EVP, Chief Business Officer

Sell

6,907

$75.75

$523.21K

BENNETT C FRANK

16 Jan 2026

EVP, Chief Scientific Officer

Sell

8,977

$75.15

$674.62K

Birchler Brian

16 Jan 2026

EVP, Corp and Development Ops

Sell

8,480

$75.11

$636.93K

Devers Shannon L.

16 Jan 2026

EVP, Chief Human Resources Ofc

Sell

8,353

$75.95

$634.41K

HOUGEN ELIZABETH L

16 Jan 2026

EVP, Finance & CFO

Sell

12,922

$75.22

$971.99K

Jenne Kyle

16 Jan 2026

EVP, Chf GL Pdt Str Ofcr

Sell

1,823

$75.96

$138.48K

Kordasiewicz Holly B.

16 Jan 2026

EVP, Chief Development Officer

Sell

4,141

$75.66

$313.31K

Monia Brett P

16 Jan 2026

Chief Executive Officer

Sell

44,034

$74.82

$3.29M

O'NEIL PATRICK R.

16 Jan 2026

EVP CLO & General Counsel

Sell

9,191

$75.84

$697.05K

Schneider Eugene

16 Jan 2026

EVP, Chf Clinical Develop Ofcr

Sell

9,302

$75.59

$703.14K

Swayze Eric

16 Jan 2026

EVP Research

Sell indirect

$75.97

$3.72K

Swayze Eric

16 Jan 2026

EVP Research

Sell

9,884

$75.34

$744.66K

Swayze Eric

16 Oct 2025

EVP Research

Sell indirect

$73.62

$3.90K

Show all 146 transactions →

IONIS PHARMACEUTICALS INC

By person

Individual transactions

What was left out